000			01995 a2200529 4500
005			20250514201231.0
264		0	_c20050425
008			200504s 0 0 eng d
022			_a1524-4539
024	7		_a10.1161/01.CIR.0000138315.99788.eb _2doi
040			_aNLM _beng _cNLM
100	1		_aLazar, Harold L
245	0	0	_aSoluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass. _h[electronic resource]
260			_bCirculation _cSep 2004
300			_aII274-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aCardiac Surgical Procedures _xmortality
650	0	4	_aCardiopulmonary Bypass _xadverse effects
650	0	4	_aComplement Activation _xdrug effects
650	0	4	_aComplement C3a _xbiosynthesis
650	0	4	_aComplement Membrane Attack Complex _xbiosynthesis
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfections _xepidemiology
650	0	4	_aInjections, Intravenous
650	0	4	_aIntra-Aortic Balloon Pumping _xstatistics & numerical data
650	0	4	_aLength of Stay _xstatistics & numerical data
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Infarction _xdiagnosis
650	0	4	_aMyocardial Ischemia _xetiology
650	0	4	_aProspective Studies
650	0	4	_aReceptors, Complement _xadministration & dosage
650	0	4	_aSex Factors
650	0	4	_aSolubility
650	0	4	_aTreatment Outcome
700	1		_aBokesch, Paula M
700	1		_avan Lenta, Frederick
700	1		_aFitzgerald, Carmel
700	1		_aEmmett, Constance
700	1		_aMarsh, Henry C
700	1		_aRyan, Una
773	0		_tCirculation _gvol. 110 _gno. 11 Suppl 1 _gp. II274-9
856	4	0	_uhttps://doi.org/10.1161/01.CIR.0000138315.99788.eb _zAvailable from publisher's website
999			_c15059297 _d15059297